IL1-blocking therapy in colchicine-resistant familial Mediterranean fever.
Kucuksahin O, et al.
Clin Exp Rheumatol · 2018
Key Findings
- ●Rapid (2-3 days) and persistent suppression of FMF symptoms
- ●Significant reduction in attack frequency (P<0.003)
- ●Well tolerated over median 2 years
Referenced in (1 disease)
Validation history
Full log →- passsource metadataJun 1, 2026, 04:40 PMby pubmed-api
Identifier corrected: prior entry (pmid-30418119) had a wrong PMID/DOI pointing to an unrelated paper; re-resolved by title to this record via PubMed/Crossref.
tools: pubmed.esummary, crossref.works
ID: pmid-30501849DOI: 10.5152/eurjrheum.2018.18036PMID: 30501849